News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Michael Chuong: Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer
Michael Chuong/mapquest.com
Jun 22, 2025, 08:59

Michael Chuong: Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer

Michael Chuong, Vice Chair and Medical Director of the Department of Radiation Oncology at Miami Cancer Institute, shared a post on LinkedIn:

“Online adaptive radiotherapy (oART) is increasingly being used to deliver high ablative dose for inoperable pancreatic cancer that may improve patient survival.
However, the benefits of oART vs. standard non-adaptive RT have not previously been reported. Such data could be beneficial to guide treatment decisions, especially since oART is a technically complex and resource intensive procedure that is currently offered at a limited number of institutions.
  •  This is the first in silico comparison of 5-fraction ablative pancreatic SBRT delivered w/ online adapted MR-guided vs. non-adapted CT-guided radiotherapy
  •  120 total treatment plans were compared
  •  Tumor coverage by an ablative dose was high in both cohorts
  •  96% of all plans violated stomach/bowel constraints w/o oART 
  •  100% of all plans met stomach/bowel constraints w/ oART 
  •  These data support the importance of oART in enhancing safety when delivering ablative 5-fraction SBRT, which ideally should be delivered at a high-volume center.”

Title: Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer: In Silico Evaluation of Interfraction Anatomic Changes as a Rationale for Online Adaptive Replanning

Authors: Adeel Kaiser, Nicole Luther, Kathryn E. Mittauer, Amna Gul, Robert A. Herrera, Mukesh K. Roy, Ashley Fellows, Amy Rzepczynski, Will Deere, Matthew D. Hall, Rupesh Kotecha, Nema Bassiri-Gharb, Alonso N. Gutierrez, Michael D. Chuong

Read the Full Article.

Michael Chuong

More posts featuring Michael Chuong on OncoDaily.

Adeel Kaiser Alonso N. Gutierrez Amna Gul Amy Rzepczynski Ashley Fellows cancer Kathryn E. Mittauer Matthew D. Hall Michael Chuong Michael D. Chuong Mukesh K. Roy Nema Bassiri-Gharb Nicole Luther OncoDaily Oncology Robert A. Herrera Rupesh Kotecha Will Deere
Special Coverage
Oncolibrary
Jun 24, 2025, 13:21
Natural Ways to Prevent Hair Loss During Chemotherapy: What Actually Works?
Stories
Jun 24, 2025, 11:46
Survivorship and Beyond: Sally Wolf Reflects on 9 Years After Chemotherapy
Blog
Jun 24, 2025, 11:38
Michael Methner: A Thriving Survivor Thanks to Progress in Cancer Research - AACR
Blog
Jun 24, 2025, 11:11
Ashok Sebastian Komaranchath: Team BCI Muscat is Bringing the Best in Cancer Care to Oman
Blog
Jun 24, 2025, 11:04
Hillary Andrews: Excited to Share That Theresa's Research Foundation's Manuscript about MARP was Published in npj Breast Cancer
Blog
Jun 24, 2025, 10:52
Miloš Grujić Shared Highlights from the 2025 ESO Masterclass in Clinical Oncology - Summer Edition
Blog
Jun 24, 2025, 10:40
Shahrin Ahmed: Gain Respect for Yourself and Build a Future That Benefits Your Family
Career
Jun 24, 2025, 10:40
Aaron Scott was Appointed Director of the Early Therapeutics Program at the University of Arizona Comprehensive Cancer Center
Insight
Jun 24, 2025, 10:34
Estela Rodriguez: FDA Grants Accelerated Approval to Dato-Dxd for Previously Treated EGFR+ NSCLC
Career
Jun 24, 2025, 10:32
Mark Everard Has Been Appointed Chair of World Child Cancer Ambassadors Group
Blog
Jun 24, 2025, 10:28
Celebrating Newly Accredited Cancer Centres at the Certificate Ceremony at OECI Oncology Days 2025
Blog
Jun 24, 2025, 10:21
Do You Ever Wonder How The Data That is Collected From the Lung Cancer Community is Used? - LUNGevity Foundation